☰

Jason D. Fontenot, Ph.D. - Publications

Affiliations: 
2003 University of Washington, Seattle, Seattle, WA 
Area:
Immunology, Molecular Biology
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ho P, Cahir-McFarland E, Fontenot JD, Lodie T, Nada A, Tang Q, Turka LA, Bluestone JA. Harnessing regulatory T cells to establish immune tolerance. Science Translational Medicine. 16: eadm8859. PMID 38478632 DOI: 10.1126/scitranslmed.adm8859  0.576
2022 Fumagalli V, Venzin V, Di Lucia P, Moalli F, Ficht X, Ambrosi G, Giustini L, Andreata F, Grillo M, Magini D, Ravà M, Friedrich C, Fontenot JD, Bousso P, Gilmore SA, et al. Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability. Science Immunology. 7: eabi6112. PMID 35213210 DOI: 10.1126/sciimmunol.abi6112  0.612
2020 Ranganath T, Simpson LJ, Ferreira AM, Seiler C, Vendrame E, Zhao N, Fontenot JD, Holmes S, Blish CA. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry. Frontiers in Immunology. 11: 714. PMID 32391016 DOI: 10.3389/Fimmu.2020.00714  0.365
2018 May-Dracka TL, Arduini R, Bertolotti-Ciarlet A, Bhisetti G, Brickelmaier M, Cahir-McFarland E, Enyedy I, Fontenot JD, Hesson T, Little K, Lyssikatos J, Marcotte D, McKee T, Murugan P, Patterson T, et al. Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity. Bioorganic & Medicinal Chemistry Letters. PMID 29636220 DOI: 10.1016/j.bmcl.2018.03.032  0.348
2017 Fontenot JD, Gavin MA, Rudensky AY. Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336. Journal of Immunology (Baltimore, Md. : 1950). 198: 986-992. PMID 28115587  0.624
2016 Chinen T, Kannan AK, Levine AG, Fan X, Klein U, Zheng Y, Gasteiger G, Feng Y, Fontenot JD, Rudensky AY. An essential role for the IL-2 receptor in Treg cell function. Nature Immunology. PMID 27595233 DOI: 10.1038/Ni.3540  0.725
2016 Gillard GO, Saenz SA, Huss DJ, Fontenot JD. Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy. Journal of Neuroimmunology. 294: 41-5. PMID 27138097 DOI: 10.1016/j.jneuroim.2016.03.008  0.39
2016 Enyedy IJ, Powell NA, Caravella J, van Vloten K, Chao J, Banerjee D, Marcotte D, Silvian L, McKenzie A, Hong VS, Fontenot JD. Discovery of biaryls as RORγ inverse agonists by using structure-based design. Bioorganic & Medicinal Chemistry Letters. PMID 27080181 DOI: 10.1016/j.bmcl.2016.03.109  0.486
2016 Huss DJ, Pellerin AF, Collette BP, Kannan AK, Peng L, Datta A, Wipke BT, Fontenot JD. Anti-CD25 monoclonal antibody Fc variants differentially impact Treg cells and immune homeostasis(1). Immunology. PMID 27012310 DOI: 10.1111/imm.12609  0.442
2016 Rosen J, Rezner B, Robbins D, Hardy I, Peralta E, Maine C, Sabouri M, Reynal S, Truong C, Moreno S, Foster H, Borchelt S, Meza M, Thompson L, Fontenot J, et al. Identification of Small Molecule Modulators to Enhance the Therapeutic Properties of Chimeric Antigen Receptor T Cells Blood. 128: 4712-4712. DOI: 10.1182/BLOOD.V128.22.4712.4712  0.572
2015 Banerjee D, Zhao L, Wu L, Palanichamy A, Ergun A, Peng L, Quigley C, Hamann S, Dunstan R, Cullen P, Allaire N, Guertin K, Wang T, Chao J, Loh C, ... Fontenot JD, et al. Small Molecule Mediated Inhibition of RORγ-Dependent Gene Expression and Autoimmune Disease Pathology In Vivo. Immunology. PMID 26694902 DOI: 10.1111/imm.12570  0.572
2015 Huss DJ, Mehta DS, Sharma A, You X, Riester KA, Sheridan JP, Amaravadi LS, Elkins JS, Fontenot JD. In vivo maintenance of human regulatory T cells during CD25 blockade. Journal of Immunology (Baltimore, Md. : 1950). 194: 84-92. PMID 25416807 DOI: 10.4049/jimmunol.1402140  0.414
2008 D'Alise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, Benoist C, Mathis D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proceedings of the National Academy of Sciences of the United States of America. 105: 19857-62. PMID 19073938 DOI: 10.1073/Pnas.0810713105  0.652
2008 Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR, Muller W, Rudensky AY. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 28: 546-58. PMID 18387831 DOI: 10.1016/J.Immuni.2008.02.017  0.71
2007 Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. The Journal of Experimental Medicine. 204: 2159-69. PMID 17709423 DOI: 10.1084/Jem.20062105  0.755
2007 Sather BD, Treuting P, Perdue N, Miazgowicz M, Fontenot JD, Rudensky AY, Campbell DJ. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. The Journal of Experimental Medicine. 204: 1335-47. PMID 17548521 DOI: 10.1084/Jem.20070081  0.747
2007 Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, Rudensky AY. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 445: 771-5. PMID 17220874 DOI: 10.1038/Nature05543  0.744
2006 Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis Journal of Immunology. 177: 5852-5860. PMID 17056509 DOI: 10.4049/Jimmunol.177.9.5852  0.586
2006 Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nature Immunology. 7: 401-10. PMID 16532000 DOI: 10.1038/Ni1318  0.781
2006 Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. Erratum: A function for interleukin 2 in Foxp3-expressing regulatory T cells Nature Immunology. 7: 427-427. DOI: 10.1038/Ni0406-427B  0.637
2006 Sather BD, Gyarmati D, Miazgowicz M, Fontenot JD, Rudensky AY, Campbell DJ. Su.135. Regulatory T-Cell Expression of CCR4 is Required to Prevent Cutaneous & Pulmonary Inflammation Clinical Immunology. 119: S206. DOI: 10.1016/J.Clim.2006.04.562  0.711
2005 Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunology. 6: 1142-51. PMID 16227984 DOI: 10.1038/Ni1263  0.738
2005 Fontenot JD, Dooley JL, Farr AG, Rudensky AY. Developmental regulation of Foxp3 expression during ontogeny Journal of Experimental Medicine. 202: 901-906. PMID 16203863 DOI: 10.1084/Jem.20050784  0.768
2005 Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nature Immunology. 6: 331-7. PMID 15785758 DOI: 10.1038/Ni1179  0.777
2005 Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22: 329-41. PMID 15780990 DOI: 10.1016/J.Immuni.2005.01.016  0.76
2004 Fontenot JD, Rudensky AY. Molecular aspects of regulatory T cell development. Seminars in Immunology. 16: 73-80. PMID 15036230 DOI: 10.1016/J.Smim.2003.12.002  0.767
2003 Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology. 4: 330-6. PMID 12612578 DOI: 10.1038/Ni904  0.679
Show low-probability matches.